Key result
Rural primary care study evaluates patient awareness and comprehension of icosapent ethyl for ASCVD risk.
Why the study?
Little is known about patient understanding of icosapent ethyl within routine primary care settings.
Observational
Mixed-methods analysis evaluates patient awareness, comprehension, and support needs regarding icosapent ethyl in rural primary care, highlighting gaps in cardiovascular risk communication.
Background and Aims: Icosapent ethyl (IPE) significantly reduces atherosclerotic cardiovascular disease (ASCVD) events in high-risk statin-treated patients, as demonstrated in REDUCE-IT and subsequent analyses. However, little is known about patient understanding of IPE within routine primary care. This analysis evaluated awareness, comprehension, and support needs among patients in a rural primary care setting in the UK.
No takes yet. Share an insight, caveat, or question.
Donaldson et al. (2026) conducted an observational in Atherosclerotic cardiovascular disease (ASCVD) risk. Icosapent ethyl (patient understanding and awareness) was evaluated on Awareness, comprehension, and support needs. Icosapent ethyl awareness and comprehension were evaluated in a rural primary care setting, but specific quantitative results were not reported in the truncated abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: